Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer

A study on ibrutinib therapy found that patients with lymphoid cancer have an increased risk of developing serious infections, including invasive fungal infections.

Clinical Infectious Diseases